Antimicrobial Management Strategies for Multidrug-Resistant Gram-Positive Prosthetic Device Infections

Burcu Isler1, Peter Simos2, Victoria Grey3

  • 1Department of Infectious Diseases, Gold Coast University Hospital, 1 Hospital Boulevard, Southport 4215, Gold Coast, QLD, Australia; Faculty of Health, Medicine & Behavioural Sciences, University of Queensland Centre for Clinical Research, Brisbane, Australia; School of Medicine and Dentistry, Griffith University, Gold Coast, Australia.

Insights

Managing multidrug-resistant (MDR) gram-positive prosthetic device infections requires surgery and antibiotics. Device removal is often key, with vancomycin a primary treatment, and newer drugs allowing outpatient care.

Area of Science:

  • Infectious Diseases
  • Medical Microbiology
  • Surgical Infections

Background:

  • Prosthetic device infections (PDIs) caused by multidrug-resistant (MDR) gram-positive bacteria present complex clinical challenges.
  • Key pathogens include methicillin-resistant staphylococci, ampicillin-resistant enterococci, vancomycin-resistant enterococci, and MDR Corynebacterium species.

Purpose of the Study:

  • To review current management strategies for PDIs caused by specific MDR gram-positive bacteria.
  • To highlight the interplay between surgical intervention and antimicrobial therapy.

Main Methods:

  • Literature review of management strategies for PDIs.
  • Analysis of antimicrobial options and surgical considerations.

Main Results:

  • Successful management necessitates a combined approach of surgical intervention and appropriate antimicrobial therapy.
  • Device removal is frequently essential for successful treatment outcomes.
  • Vancomycin is a cornerstone antimicrobial, while agents like dalbavancin offer outpatient treatment possibilities.
  • Linezolid use requires monitoring for toxicity during extended therapy.

Conclusions:

  • Surgical approach significantly influences outcomes, often more than antimicrobial choice alone.
  • Coordinated multidisciplinary care is critical for optimizing PDI management.
  • Emerging therapies provide new avenues for treating challenging PDI cases.

Related Concept Videos

Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
197
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
285
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
297
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
726
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
220
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
230